This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • Phase III study of Saxenda in adolescent obesity p...
News

Phase III study of Saxenda in adolescent obesity published in New England Journal of Medicine.- Novo Nordisk

Read time: 1 mins
Published:1st Apr 2020
Condition: Obesity
Type: drug
Register now for full access to medthority.com